about
Treatment of primary osteoporosis in menThe ratio of anterior and posterior vertebral heights reinforces the utility of DXA in assessment of vertebrae strength.Annatto tocotrienol improves indices of bone static histomorphometry in osteoporosis due to testosterone deficiency in rats.Effect of the combined extracts of herba epimedii and fructus ligustri lucidi on sex hormone functional levels in osteoporosis rats.Bone loss in obesity and obstructive sleep apnea: a review of literature.Osteoporosis in men: a review.Sarcopenia in daily practice: assessment and management.Bisphosphonate-related osteonecrosis of the jaw in a patient with osteoporosis following treatment of testicular cancer: a case reportCauses, consequences, and treatment of osteoporosis in men.Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab.The Effects of Annatto Tocotrienol on Bone Biomechanical Strength and Bone Calcium Content in an Animal Model of Osteoporosis Due to Testosterone Deficiency.Male Hypogonadism and Osteoporosis: The Effects, Clinical Consequences, and Treatment of Testosterone Deficiency in Bone Health.Safety concerns with the long-term management of osteoporosis.(Patho)physiology of cross-sex hormone administration to transsexual people: the potential impact of male-female genetic differences.Cross-cultural adaptation and content validation of START.Factors associated with the accuracy of self-reported osteoporosis in the community.Bisphosphonate related osteonecrosis of the jaws (BRONJ) in osteoporotic males.Relation between osteoporosis and radiographic and clinical signs of osteoarthritis/arthrosis in the temporomandibular joint: a population-based, cross-sectional study in an older Swedish population.A case-control study assessing bone mineral density in severe haemophilia A in the UK.Evaluation of bone mineral density (BMD) and indicators of bone turnover in patients with hemophilia.The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation.Cancer Treatment-Induced Bone Loss in Women With Breast Cancer and Men With Prostate Cancer.Effect of tocotrienol from Bixa orellana (annatto) on bone microstructure, calcium content, and biomechanical strength in a model of male osteoporosis induced by buserelin.
P2860
Q26991748-A67D579A-8687-400C-9655-3E5AD6D701A0Q33922107-CC12845B-DF48-4FE9-8CB5-661D32299B4CQ34578059-6D5F8850-CB58-4550-9183-37C2167B8BCDQ35010146-8E262DE6-958F-4BCA-BFBB-2DE6FD2E7ECFQ35542061-A301C462-31F6-4EA0-A77C-40CFF7619546Q35755160-3AB28D27-2671-49A8-B6AB-FAAC42136250Q36157098-0EFC1A08-27C3-4BDE-B94F-5FE5513832A5Q36426563-E990ED92-E12E-47D9-9A19-93CBBFA6BBB2Q37134718-8CD1080E-4AEF-4144-ABE6-A00B8D514844Q37469798-51499CE0-FF03-4690-9A6B-4B1AE996A1A4Q37535500-A09C8FBE-1597-4265-B37C-395BD7431AFBQ37733627-669D08B8-AE04-48F3-9FC7-0E09F44CCB65Q38101363-029A6760-F618-49FF-A8D1-1DCF3BCD2A94Q38286224-89C2BB50-AEB7-42A8-AF16-0EB47BE1555AQ38703260-40D0F44B-575C-4E0E-9992-B3E63D9BA18CQ39314162-06DAC5FE-5847-41B0-9B8A-61183C640812Q39367690-BC994F15-E11F-4FF7-92CC-680906ADFACEQ39583620-885A1560-D579-4139-8F21-E925113AB083Q45870056-4AA5A4A8-BDC8-4760-8473-E407A5A32F79Q45875787-B41394C4-1630-4E83-80EF-07DB6629891AQ47138098-5375E855-668D-4FEC-8EDB-EEFBAF288256Q55322511-F4A79F05-764C-4F5A-ACC7-A545625A38B5Q55373105-5A61A66D-6FD3-43BF-A28E-D066A9E9D489
P2860
description
scientific article published on 28 November 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2013
@uk
name
Treatment of osteoporosis in men
@en
Treatment of osteoporosis in men
@nl
type
label
Treatment of osteoporosis in men
@en
Treatment of osteoporosis in men
@nl
prefLabel
Treatment of osteoporosis in men
@en
Treatment of osteoporosis in men
@nl
P2093
P2860
P50
P1433
P1476
Treatment of osteoporosis in men
@en
P2093
E McCloskey
J-M Kaufman
J-P Devogelaer
J-Y Reginster
M L Brandi
P2860
P304
P356
10.1016/J.BONE.2012.11.018
P407
P577
2012-11-28T00:00:00Z